TNF and cancer: The ligand binding between TLR and antigen would activate the transcription factors nuclear factor kappa B (NF-B), interferon, and the release of cytokines such as IL6, IL1, IL8, IL12, TNF, and other molecules such as CD40, CD80, and CD86, which would lead to the recruitment of immune cells and, subsequently, induce killing mechanisms in cancer cells [117].